Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Intervalo de año de publicación
1.
Rev Soc Bras Med Trop ; 51(1): 66-70, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29513845

RESUMEN

INTRODUCTION: Pseudo-infectious yellow fever viral particles (YFV-PIVs) have been used to study vaccines and viral packaging. Here, we report the development of a packaging cell line, which expresses the YFV prM/E proteins. METHODS: HEK293 cells were transfected with YFV prM/E and C (84 nt) genes to generate HEK293-YFV-PrM/E-opt. The cells were evaluated for their ability to express the heterologous proteins and to package the replicon repYFV-17D-LucIRES, generating YFV-PIVs. RESULTS: The expression of prM/E proteins was confirmed, and the cell line trans-packaged the replicon for recovery of a reporter for the YFV-PIVs. CONCLUSIONS: HEK293-YFV-prM/E-opt trans-packaging capacity demonstrates its possible biotechnology application.


Asunto(s)
Vacunas de Partículas Similares a Virus/inmunología , Ensamble de Virus/inmunología , Replicación Viral/inmunología , Virus de la Fiebre Amarilla/inmunología , Citometría de Flujo , Técnica del Anticuerpo Fluorescente Indirecta , Proteínas Fluorescentes Verdes , Células HEK293 , Humanos , Vacunas de Partículas Similares a Virus/genética , Ensamble de Virus/genética , Replicación Viral/genética , Virus de la Fiebre Amarilla/genética
2.
Rev. Soc. Bras. Med. Trop ; Rev. Soc. Bras. Med. Trop;51(1): 66-70, Jan.-Feb. 2018. graf
Artículo en Inglés | LILACS | ID: biblio-1041442

RESUMEN

Abstract INTRODUCTION: Pseudo-infectious yellow fever viral particles (YFV-PIVs) have been used to study vaccines and viral packaging. Here, we report the development of a packaging cell line, which expresses the YFV prM/E proteins. METHODS: HEK293 cells were transfected with YFV prM/E and C (84 nt) genes to generate HEK293-YFV-PrM/E-opt. The cells were evaluated for their ability to express the heterologous proteins and to package the replicon repYFV-17D-LucIRES, generating YFV-PIVs. RESULTS: The expression of prM/E proteins was confirmed, and the cell line trans-packaged the replicon for recovery of a reporter for the YFV-PIVs. CONCLUSIONS: HEK293-YFV-prM/E-opt trans-packaging capacity demonstrates its possible biotechnology application.


Asunto(s)
Humanos , Replicación Viral/inmunología , Virus de la Fiebre Amarilla/inmunología , Ensamble de Virus/inmunología , Vacunas de Partículas Similares a Virus/inmunología , Replicación Viral/genética , Virus de la Fiebre Amarilla/genética , Ensamble de Virus/genética , Técnica del Anticuerpo Fluorescente Indirecta , Proteínas Fluorescentes Verdes , Células HEK293 , Vacunas de Partículas Similares a Virus/genética , Citometría de Flujo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA